Glaukos Corporation
GKOS
$93.29
$1.741.90%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/26/2025
-
MarketBeat
8/25/2025
-
MarketBeat
8/23/2025
-
MarketBeat
8/22/2025
-
MarketBeat
8/22/2025
-
MarketBeat
8/21/2025
-
ETF Channel
8/20/2025
-
MarketBeat
8/20/2025
-
Tickeron - Stocks
8/17/2025
-
MarketBeat
8/17/2025
-
GuruFocus
8/16/2025
-
MarketBeat
8/15/2025
-
Tickeron - Stocks
8/15/2025
-
MarketBeat
8/14/2025
-
Tickeron - Technical Analysis
8/14/2025
-
GuruFocus
8/13/2025
-
GuruFocus
8/13/2025
-
GuruFocus
8/13/2025
-
Business Wire
8/12/2025
-
Simply Wall St
8/11/2025
-
MarketBeat
8/11/2025
-
Ticker Report
8/10/2025
-
Ticker Report
8/7/2025
-
MarketBeat
8/7/2025
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 4, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
949 367 9600
Address
One Glaukos Way
Aliso Viejo, CA 92656
Aliso Viejo, CA 92656
Country
Year Founded
Business Description
Sector
Industry
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States...
more